ProteinQure Alternatives & Competitors
12 companies similar to ProteinQure — dare to deliver
Companies similar to ProteinQure
Perpetual Medicines
AI-powered computational platform for peptide drug discovery
Menten AI
Unlocking the potential of peptides macrocycles to create tomorrow's life-changing medicin...
San Francisco, United Sta...
Manifold Bio
Organism-scale intelligence, designed in vivo
Boston, United States
Rival Readout
Competing with ProteinQure? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
Antiverse
Designing functional antibodies for the most challenging targets.
Cardiff, United Kingdom
Mosaic TX
Resolving cancer's complexity through the power of targeted drug combinations
United Kingdom
BlossomHill Therapeutics, Inc.
Addressing urgent unmet medical needs through deeper science, true originality, and rich e...
San Diego, United States
AnaBios Corporation
The Power of the Human Model
San Diego, United States
Syntekabio Inc.
AI Platform for Drug Discovery & Precision Medicine (226330:KOSDAQ)
New York, United States
WhiteLab Genomics
Unleash the Potential of Genomic Medicine Using AI
Paris, France
About ProteinQure
ProteinQure, founded in 2017 and headquartered in Canada, is at the forefront of biotechnology. Armed with the slogan "dare to deliver," the company is pioneering an AI platform designed for peptide drug design, particularly targeting extracellular targets. Their flagship program, PQ203, is currently undergoing Phase I...
Development of AI-designed peptide-drug conjugates, Precision drug delivery solutions, Proprietary computational platform (ProteinStudio) for peptide design, Clinical trials for peptide-based therapeutics, Research and development in oncology solutions
Pharmaceutical companies, Biotech researchers, Clinical oncology specialists, Medical research institutions, Patients with advanced solid tumors
AI Platform For Drug Design, Peptide Drug Design, Extracellular Targets, TOP1-resistant Breast Cancer, Phase I Clinical Trials, Pharmaceutical Collaborations, Proprietary Physics-based Methods, Chemical Space Exploration, Scaffold Diversity, Non-canonical Building Blocks, Tissue-specific Payload Delivery, SiRNA Delivery, Central Nervous System Therapies
B2B, Platform, SaaS
Performance Based, Licensing, Project Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around ProteinQure: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at ProteinQure on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
